A randomized, double-blind, placebo-controlled phase II study of maintenance therapy with tasquinimod (TASQ) in patients (pts) with mCRPC responsive to or stabilized during first-line docetaxel chemotherapy

Karim Fizazi; Albertas Ulys; Lisa Sengeløv; Mette Moe Kempel; Sylvain Ladoire; Antoine Thiery-Vuillemin; Aude Flechon; Roberto Sabbatini; Joaquim Bellmunt; Miguel Angel Climent; Simon Chowdhury; Herlinde Dumez; Michaela Matouskova; Nicolas Penel; Sigita Liutkauskiene; Lech Stachurski; Cora N. Sternberg; Frederique Baton; Nathalie Germann; Gedske Daugaard

A randomized, double-blind, placebo-controlled phase II study of maintenance therapy with tasquinimod (TASQ) in patients (pts) with mCRPC responsive to or stabilized during first-line docetaxel chemotherapy

Karim Fizazi, Albertas Ulys, Lisa Sengeløv, Mette Moe Kempel, Sylvain Ladoire, Antoine Thiery-Vuillemin, Aude Flechon, Roberto Sabbatini, Joaquim Bellmunt, Miguel Angel Climent, Simon Chowdhury, Herlinde Dumez, Michaela Matouskova, Nicolas Penel, Sigita Liutkauskiene, Lech Stachurski, Cora N. Sternberg, Frederique Baton, Nathalie Germann, Gedske Daugaard

Research output: Contribution to journal › Conference abstract in journal › Research › peer-review

Original language	English
Article number	201
Journal	Journal of Clinical Oncology
Volume	34
Issue number	2 Suppl.
ISSN	0732-183X
Publication status	Published - 2016
Event	Genitourinary Cancers Symposium - San Francisco, United States Duration: 7 Jan 2016 → 9 Jan 2016

Conference

Conference	Genitourinary Cancers Symposium
Country/Territory	United States
City	San Francisco
Period	07/01/2016 → 09/01/2016

Access to Document

http://meeting.ascopubs.org/cgi/content/abstract/34/2_suppl/201?sid=97cf32bc-44a3-4c0e-9658-56b012b393ee

AUB Link

Search for the material in Aalborg University Library's search engine

Cite this

Fizazi, K., Ulys, A., Sengeløv, L., Kempel, M. M., Ladoire, S., Thiery-Vuillemin, A., Flechon, A., Sabbatini, R., Bellmunt, J., Climent, M. A., Chowdhury, S., Dumez, H., Matouskova, M., Penel, N., Liutkauskiene, S., Stachurski, L., Sternberg, C. N., Baton, F., Germann, N., & Daugaard, G. (2016). A randomized, double-blind, placebo-controlled phase II study of maintenance therapy with tasquinimod (TASQ) in patients (pts) with mCRPC responsive to or stabilized during first-line docetaxel chemotherapy. Journal of Clinical Oncology, 34(2 Suppl.), [201]. http://meeting.ascopubs.org/cgi/content/abstract/34/2_suppl/201?sid=97cf32bc-44a3-4c0e-9658-56b012b393ee

@article{287ebf16f4324c79846b7e402f69466e,

title = "A randomized, double-blind, placebo-controlled phase II study of maintenance therapy with tasquinimod (TASQ) in patients (pts) with mCRPC responsive to or stabilized during first-line docetaxel chemotherapy",

author = "Karim Fizazi and Albertas Ulys and Lisa Sengel{\o}v and Kempel, {Mette Moe} and Sylvain Ladoire and Antoine Thiery-Vuillemin and Aude Flechon and Roberto Sabbatini and Joaquim Bellmunt and Climent, {Miguel Angel} and Simon Chowdhury and Herlinde Dumez and Michaela Matouskova and Nicolas Penel and Sigita Liutkauskiene and Lech Stachurski and Sternberg, {Cora N.} and Frederique Baton and Nathalie Germann and Gedske Daugaard",

year = "2016",

language = "English",

volume = "34",

journal = "Journal of Clinical Oncology",

issn = "0732-183X",

publisher = "American Society of Clinical Oncology",

number = "2 Suppl.",

note = "Genitourinary Cancers Symposium ; Conference date: 07-01-2016 Through 09-01-2016",

}

Fizazi, K, Ulys, A, Sengeløv, L, Kempel, MM, Ladoire, S, Thiery-Vuillemin, A, Flechon, A, Sabbatini, R, Bellmunt, J, Climent, MA, Chowdhury, S, Dumez, H, Matouskova, M, Penel, N, Liutkauskiene, S, Stachurski, L, Sternberg, CN, Baton, F, Germann, N & Daugaard, G 2016, 'A randomized, double-blind, placebo-controlled phase II study of maintenance therapy with tasquinimod (TASQ) in patients (pts) with mCRPC responsive to or stabilized during first-line docetaxel chemotherapy', Journal of Clinical Oncology, vol. 34, no. 2 Suppl., 201. <http://meeting.ascopubs.org/cgi/content/abstract/34/2_suppl/201?sid=97cf32bc-44a3-4c0e-9658-56b012b393ee>

A randomized, double-blind, placebo-controlled phase II study of maintenance therapy with tasquinimod (TASQ) in patients (pts) with mCRPC responsive to or stabilized during first-line docetaxel chemotherapy. / Fizazi, Karim; Ulys, Albertas; Sengeløv, Lisa et al.
In: Journal of Clinical Oncology, Vol. 34, No. 2 Suppl., 201, 2016.

Research output: Contribution to journal › Conference abstract in journal › Research › peer-review

TY - ABST

T1 - A randomized, double-blind, placebo-controlled phase II study of maintenance therapy with tasquinimod (TASQ) in patients (pts) with mCRPC responsive to or stabilized during first-line docetaxel chemotherapy

AU - Fizazi, Karim

AU - Ulys, Albertas

AU - Sengeløv, Lisa

AU - Kempel, Mette Moe

AU - Ladoire, Sylvain

AU - Thiery-Vuillemin, Antoine

AU - Flechon, Aude

AU - Sabbatini, Roberto

AU - Bellmunt, Joaquim

AU - Climent, Miguel Angel

AU - Chowdhury, Simon

AU - Dumez, Herlinde

AU - Matouskova, Michaela

AU - Penel, Nicolas

AU - Liutkauskiene, Sigita

AU - Stachurski, Lech

AU - Sternberg, Cora N.

AU - Baton, Frederique

AU - Germann, Nathalie

AU - Daugaard, Gedske

PY - 2016

Y1 - 2016

M3 - Conference abstract in journal

SN - 0732-183X

VL - 34

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

IS - 2 Suppl.

M1 - 201

T2 - Genitourinary Cancers Symposium

Y2 - 7 January 2016 through 9 January 2016

ER -